Cargando…
Heparin binding protein in severe COVID-19—A prospective observational cohort study
BACKGROUND AND AIMS: Neutrophil-derived heparin binding protein (HBP; also known as azurocidin or CAP-37) is a key player in bacterial sepsis and a promising biomarker in severe infections. The aims of this study were to assess whether HBP is involved in the pathophysiology of COVID-19 and, if so, w...
Autores principales: | Mellhammar, Lisa, Thelaus, Louise, Elén, Sixten, Fisher, Jane, Linder, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023466/ https://www.ncbi.nlm.nih.gov/pubmed/33822821 http://dx.doi.org/10.1371/journal.pone.0249570 |
Ejemplares similares
-
The Dynamics of Circulating Heparin-Binding Protein: Implications for Its Use as a Biomarker
por: Fisher, Jane, et al.
Publicado: (2021) -
Heparin-binding protein in lower airway samples as a biomarker for pneumonia
por: Paulsson, Magnus, et al.
Publicado: (2021) -
New, Useful Criteria for Assessing the Evidence of Infection in Sepsis Research
por: Mellhammar, Lisa, et al.
Publicado: (2022) -
Heparin-binding protein is important for vascular leak in sepsis
por: Bentzer, Peter, et al.
Publicado: (2016) -
Heparin-binding protein (HBP) improves prediction of sepsis-related acute kidney injury
por: Tverring, Jonas, et al.
Publicado: (2017)